MedWatch

Denmark takes decisive step towards introducing bar codes on medicine in 2019

The Danish pharmaceutical industry has received a new European approval, which means that Denmark is well on its way to introducing manufacturer-paid bar codes on medicine that the EU requires to be introduced before February 2019, and which has cost Novo an investment of more than DKK 100 million (USD 16.6 million).

A real viagra pill from Pfizer (in the middle) in a pile of fakes. The EU wants to remove any doubt about counterfeit medicine with a new bar code system, and Denmark is well on its way to introduce it. Photo: Pfizer

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

EU vil beskytte europæiske virksomheder mod USA's Iran-sanktioner

Europæiske virksomheder skal beskyttes mod sanktioner, som USA indfører mod Iran, skriver EU-Kommissionen. I udgangspunktet positivt, men i praksis svært ladsiggørligt vurderer DI, der stadig mener, at danske medicinalselskaber, som opererer i Iran, vil blive ramt negativt. Novo Nordisk afventer situationen.

Her er de vigtigste nyheder fra MedWatch i uge 20

Præsidentielle udfald i USA, fusion i høreapparatsbranchen, rehab-messe i Bella Center og udskiftning i Novo-toppen - MedWatch giver dig overblikket over ugens vigtigste nyheder fra dansk life science. Gik du glip af noget?

Related articles